CHMP Backs Antifungal Isavuconazole (Cresemba)CHMP Backs Antifungal Isavuconazole (Cresemba)

The triazole antifungal is indicated for treatment of adults with invasive aspergillosis and mucormycosis in patients for whom amphotericin B is not appropriate. Orphan Drug Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news